Dishman Carbogen Amics Ltd
DCAL
Company Profile
Business description
Dishman Carbogen Amics Ltd is engaged in Contract Development and Manufacturing Organization (CDMO) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals, and disinfectants. Its business segments include Contract Development and Manufacturing Organization (CDMO), quats, specialty chemicals, Vitamins D3 and its analogues, and cholesterols. The Company operates in India, Europe, China, and the rest of the World.
Contact
Iscon-Bopal Road
Dishman Corporate House
Ambli
AhmedabadGJ380 058
INDT: +91 2717400102
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2027
Employees
1,649
Stocks News & Analysis
stocks
Chip stock selloff deepens in Asia, extends to Europe and US
The week’s tech stock rout continues despite strong earnings from TSMC and ASML.
stocks
Downgrade for ASX listed fund manager as redemptions pile on
Persistent outflows erode earnings outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,940.40 | 100.00 | 1.13% |
| CAC 40 | 7,956.70 | 22.00 | 0.28% |
| DAX 40 | 25,622.61 | 239.99 | 0.95% |
| Dow JONES (US) | 52,002.41 | 175.28 | -0.34% |
| FTSE 100 | 10,881.90 | 41.55 | 0.38% |
| HKSE | 24,186.83 | 124.11 | 0.52% |
| NASDAQ | 26,140.03 | 572.99 | -2.14% |
| Nikkei 225 | 65,324.29 | 898.34 | 1.39% |
| NZX 50 Index | 13,753.73 | 79.07 | -0.57% |
| S&P 500 | 7,659.44 | 84.62 | -1.09% |
| S&P/ASX 200 | 8,806.70 | 87.00 | 1.00% |
| SSE Composite Index | 3,716.28 | 8.81 | 0.24% |